β 2 -Adrenergic receptor agonism as a therapeutic strategy for kidney disease

Approximately 14% of the general population suffer from chronic kidney disease that can lead to acute kidney injury (AKI), a condition with up to 50% mortality for which there is no effective treatment. Hypertension, diabetes, and cardiovascular disease are the main comorbidities, and more than 660,...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American journal of physiology. Regulatory, integrative and comparative physiology integrative and comparative physiology, 2021-05, Vol.320 (5), p.R575-R587
Hauptverfasser:	Kamiar, Ali, Yousefi, Keyvan, Dunkley, Julian C, Webster, Keith A, Shehadeh, Lina A
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-2 Receptor Agonists - therapeutic use Animals Humans Kidney - drug effects Kidney - metabolism Kidney - physiopathology Kidney Diseases - drug therapy Kidney Diseases - metabolism Kidney Diseases - physiopathology Receptors, Adrenergic, beta-2 - drug effects Receptors, Adrenergic, beta-2 - metabolism Signal Transduction Water-Electrolyte Balance - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!